ArticleScientific reports2025
Atherogenic index of plasma and cardiovascular outcomes in female patients undergoing percutaneous coronary intervention: insights from a retrospective cohort study.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- SLC16A1 lactylation links epimetabolic reprogramming of triglycerides (50:3 and 50:1) to blood pressure regulation.SAGE open medicine · 2026Article
- Comparative discriminatory performance of emerging endocrine-metabolic indices versus obesity indices for cardiometabolic multimorbidity in older adults: a cross-sectional study.Frontiers in endocrinology · 2026Article
- Atherogenic Index of Plasma (AIP) as a Long-Term Prognostic Factor Following CABG: Unveiling Insights From a Large-Scale Tertiary Center Registry Analysis.Health science reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In this research, we explored the relationship between the AIP and clinical outcomes in patients undergoing PCI. A total of 2533 consecutive patients who underwent PCI were included in this retrospective cohort study, and the data from 2098 patients were used. AIP is calculated based on the log (triglycerides/high-density lipoprotein-cholesterol). MACCEs were defined at 29.8 months as a composite of all-cause mortality, AMI, repeat revascularization and stroke. An analysis of logistic regression proportional hazards was conducted to investigate the association between AIP and the prevalence of MACCEs. This study found that there was an association between MACCEs and age (p < 0.001), heart failure history (p < 0.001), previous AMI (p = 0.013), and diabetes mellitus(p = 0.002), LVEF (p < 0.001), DBP (p = 0.027), creatinine (p = 0.002), UA (p = 0.021), ACEI treatment (p = 0.003), number of diseased vessels, target lesion location, CTO (p < 0.001), stent length (p < 0.001), and stent diameter (p < 0.001). Multivariate logistic regression analysis showed that AIP was an independent prognostic factor for MACCE in female patients (OR = 2.45, 95%CI = 1.17 ~ 5.11, p = 0.018) but not in male patients. Our findings revealed a significant correlation between AIP and MACCEs in female patients.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.